Latest Breaking News On - Twitter facebook linkedin instagram - Page 1 : comparemela.com

 E-Mail A test which uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to research published today. A team at the University of Leeds collaborated with researchers at Roche Diagnostics to develop the technique, which will help doctors and patients to decide on the best treatment options. They used samples from a previous trial funded by Cancer Research UK to look at the levels of two proteins, known as AREG and EREG, which are produced by some colorectal cancers. Algorithms driven by AI enabled the researchers to show that patients with higher levels of these proteins received significant benefit from a treatment which inhibits a different protein involved in cancer cell growth, known as EGFR. Of equal importance, patients with low levels of the proteins did not benefit from the treatment.

United kingdomNorthern irelandNorth yorkshireFacebook linkedin instagramChristopher williamsKersti mitchellKandavel shanmugamRosalind franklinResearch excellence frameworkNational teaching fellowshipsYorkshire cancer researchCancer research united kingdomLeeds university division of pathologyNational pathology imagingUniversity of leedsQs world university rankings